HomeAmgen Inc

Amgen Inc

Amgen’s Rocatinlimab Shows Promising Results

Amgen’s Rocatinlimab Shows Promising Results

September 27, 2024

Amgen Skyrockets as CEO Touts MariTide Obesity Drug Progress

Amgen Skyrockets as CEO Touts MariTide Obesity Drug Progress

May 3, 2024

Should You Buy Amgen Stock for Its 3% Yield?

Should You Buy Amgen Stock for Its 3% Yield?

April 29, 2024

Amgen Reduces Its Sales Forecast After Announcing Plans To Acquire ChemoCentryx

Amgen Reduces Its Sales Forecast After Announcing Plans To Acquire ChemoCentryx

August 5, 2022